Hong Kong-listed Chaoju Eye Care Holdings Limited reported that its issued share capital remained unchanged at 701.46 million ordinary shares as of 10 September 2026, with no shares held in treasury.

On 10 September 2026 the group repurchased 8,500 shares on the Stock Exchange of Hong Kong at prices ranging between HKD 2.505 and HKD 2.520, spending a total of HKD 21,404.70. These shares are earmarked for cancellation.

The latest transaction brings the amount of stock bought but not yet cancelled between 31 August and 10 September 2026 to 1.74 million shares—about 0.25 % of the current issued share base—at volume-weighted average prices of HKD 2.38 to HKD 2.55.

Since the adoption of its general repurchase mandate on 12 May 2026, Chaoju Eye Care has repurchased 5.08 million shares, equivalent to 0.72 % of the company’s outstanding shares on the mandate date. The mandate authorises buy-backs of up to 70.52 million shares, leaving approximately 65.44 million shares, or 9.34 % of the existing share capital, available for future purchases.

In line with Hong Kong listing rules, the company is subject to a 30-day moratorium on issuing new shares following the latest repurchase, expiring on 10 October 2026.